Exicure, Inc. (NASDAQ:XCUR) Sees Significant Decrease in Short Interest

Exicure, Inc. (NASDAQ:XCUR) was the recipient of a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 50,600 shares, a decline of 17.3% from the December 15th total of 61,200 shares. Based on an average trading volume of 727,200 shares, the days-to-cover ratio is currently 0.1 days. Currently, 21.5% of the company’s shares are sold short.

Exicure Stock Performance

Shares of Exicure stock opened at $8.89 on Friday. Exicure has a 52-week low of $1.44 and a 52-week high of $36.00. The company has a fifty day moving average of $14.84 and a 200-day moving average of $6.23. The stock has a market capitalization of $23.20 million, a price-to-earnings ratio of -4.29 and a beta of 3.81.

About Exicure

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.